nodes	percent_of_prediction	percent_of_DWPC	metapath
Ingenol Mebutate—PRKCA—Signaling events regulated by Ret tyrosine kinase—PDLIM7—pharynx cancer	0.0883	0.15	CbGpPWpGaD
Ingenol Mebutate—PRKCD—saliva-secreting gland—pharynx cancer	0.0653	0.159	CbGeAlD
Ingenol Mebutate—PRKCD—trachea—pharynx cancer	0.0504	0.122	CbGeAlD
Ingenol Mebutate—PRKCA—neck—pharynx cancer	0.0462	0.112	CbGeAlD
Ingenol Mebutate—PRKCD—lymphoid tissue—pharynx cancer	0.0439	0.107	CbGeAlD
Ingenol Mebutate—PRKCD—head—pharynx cancer	0.0354	0.0859	CbGeAlD
Ingenol Mebutate—PRKCA—brainstem—pharynx cancer	0.0353	0.0857	CbGeAlD
Ingenol Mebutate—PRKCA—epithelium—pharynx cancer	0.0314	0.0763	CbGeAlD
Ingenol Mebutate—PRKCD—lymph node—pharynx cancer	0.0248	0.0601	CbGeAlD
Ingenol Mebutate—PRKCA—lymphoid tissue—pharynx cancer	0.0242	0.0587	CbGeAlD
Ingenol Mebutate—PRKCA—EGFR Transactivation by Gastrin—EGFR—pharynx cancer	0.0234	0.0398	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptotic cleavage of cellular proteins—CDH1—pharynx cancer	0.022	0.0374	CbGpPWpGaD
Ingenol Mebutate—PRKCA—spinal cord—pharynx cancer	0.0219	0.0533	CbGeAlD
Ingenol Mebutate—PRKCA—head—pharynx cancer	0.0195	0.0473	CbGeAlD
Ingenol Mebutate—PRKCD—B Cell Receptor Signaling Pathway—CD79A—pharynx cancer	0.0187	0.0317	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Trk receptor signaling mediated by PI3K and PLC-gamma—CCND1—pharynx cancer	0.0171	0.0291	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptotic execution phase—CDH1—pharynx cancer	0.0171	0.0291	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.0137	0.0234	CbGpPWpGaD
Ingenol Mebutate—PRKCA—lymph node—pharynx cancer	0.0136	0.0331	CbGeAlD
Ingenol Mebutate—PRKCD—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.0134	0.0228	CbGpPWpGaD
Ingenol Mebutate—PRKCA—a6b1 and a6b4 Integrin signaling—CDH1—pharynx cancer	0.011	0.0188	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway—CCND1—pharynx cancer	0.0104	0.0177	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Thromboxane A2 receptor signaling—EGFR—pharynx cancer	0.00944	0.016	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Pathogenic Escherichia coli infection—CDH1—pharynx cancer	0.0094	0.016	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.00886	0.0151	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—MMP8—pharynx cancer	0.00854	0.0145	CbGpPWpGaD
Ingenol Mebutate—PRKCD—LPA receptor mediated events—EGFR—pharynx cancer	0.00848	0.0144	CbGpPWpGaD
Ingenol Mebutate—PRKCD—AGE/RAGE pathway—EGFR—pharynx cancer	0.00827	0.0141	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGFR interacts with phospholipase C-gamma—EGFR—pharynx cancer	0.00789	0.0134	CbGpPWpGaD
Ingenol Mebutate—PRKCA—PLCG1 events in ERBB2 signaling—EGFR—pharynx cancer	0.00772	0.0131	CbGpPWpGaD
Ingenol Mebutate—PRKCD—p53 pathway—TP53—pharynx cancer	0.0076	0.0129	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—CCND1—pharynx cancer	0.00744	0.0127	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway Netpath—CCND1—pharynx cancer	0.00733	0.0125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—CDH1—pharynx cancer	0.00715	0.0121	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—CCND1—pharynx cancer	0.00711	0.0121	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00703	0.012	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00695	0.0118	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ATF-2 transcription factor network—CCND1—pharynx cancer	0.00663	0.0113	CbGpPWpGaD
Ingenol Mebutate—PRKCA—a6b1 and a6b4 Integrin signaling—EGFR—pharynx cancer	0.00646	0.011	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway—CCND1—pharynx cancer	0.00598	0.0102	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00584	0.00993	CbGpPWpGaD
Ingenol Mebutate—PRKCD—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00571	0.0097	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—EGFR—pharynx cancer	0.00558	0.00948	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Thromboxane A2 receptor signaling—EGFR—pharynx cancer	0.00542	0.00921	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—CCND1—pharynx cancer	0.00509	0.00865	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Wnt Signaling Pathway and Pluripotency—TP53—pharynx cancer	0.0049	0.00834	CbGpPWpGaD
Ingenol Mebutate—PRKCA—AGE/RAGE pathway—EGFR—pharynx cancer	0.00475	0.00808	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB Signaling Pathway—TP53—pharynx cancer	0.00468	0.00796	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—B4GALT5—pharynx cancer	0.0044	0.00748	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00431	0.00733	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—CCND1—pharynx cancer	0.00428	0.00727	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Downstream signal transduction—EGFR—pharynx cancer	0.00405	0.00689	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Oncostatin M Signaling Pathway—TP53—pharynx cancer	0.00404	0.00687	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR—EGFR—pharynx cancer	0.00403	0.00686	CbGpPWpGaD
Ingenol Mebutate—PRKCD—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.00403	0.00686	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by ERBB2—EGFR—pharynx cancer	0.00401	0.00682	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—EGFR—pharynx cancer	0.00399	0.00679	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 signaling—EGFR—pharynx cancer	0.00399	0.00679	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—EGFR—pharynx cancer	0.00392	0.00666	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—CCND1—pharynx cancer	0.00381	0.00647	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00376	0.00639	CbGpPWpGaD
Ingenol Mebutate—PRKCD—DAP12 interactions—EGFR—pharynx cancer	0.00376	0.00639	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR—EGFR—pharynx cancer	0.00372	0.00633	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00369	0.00627	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by PDGF—EGFR—pharynx cancer	0.00368	0.00625	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Apoptosis—TP53—pharynx cancer	0.00351	0.00596	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways in Glioblastoma—TP53—pharynx cancer	0.00335	0.0057	CbGpPWpGaD
Ingenol Mebutate—PRKCD—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00333	0.00566	CbGpPWpGaD
Ingenol Mebutate—PRKCD—MAPK Signaling Pathway—TP53—pharynx cancer	0.00329	0.00559	CbGpPWpGaD
Ingenol Mebutate—PRKCA—ErbB1 downstream signaling—EGFR—pharynx cancer	0.00328	0.00557	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00322	0.00547	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—EGFR—pharynx cancer	0.00299	0.00507	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Wnt Signaling Pathway and Pluripotency—TP53—pharynx cancer	0.00282	0.00479	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—CNDP2—pharynx cancer	0.00279	0.00475	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Extracellular matrix organization—CDH1—pharynx cancer	0.00268	0.00456	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CD79A—pharynx cancer	0.00261	0.00444	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by SCF-KIT—EGFR—pharynx cancer	0.00259	0.0044	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—CCND1—pharynx cancer	0.00259	0.0044	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by NGF—EGFR—pharynx cancer	0.00256	0.00435	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—B4GALT5—pharynx cancer	0.00253	0.00429	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ADH7—pharynx cancer	0.00252	0.00429	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Spinal Cord Injury—TP53—pharynx cancer	0.00251	0.00426	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signaling of activated FGFR—EGFR—pharynx cancer	0.00248	0.00421	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Downstream signal transduction—EGFR—pharynx cancer	0.00233	0.00396	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR—EGFR—pharynx cancer	0.00232	0.00394	CbGpPWpGaD
Ingenol Mebutate—PRKCA—EGF/EGFR Signaling Pathway—EGFR—pharynx cancer	0.00232	0.00394	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by ERBB2—EGFR—pharynx cancer	0.00231	0.00392	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 signaling—EGFR—pharynx cancer	0.00229	0.0039	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—ADH1B—pharynx cancer	0.00221	0.00376	CbGpPWpGaD
Ingenol Mebutate—PRKCA—DAP12 interactions—EGFR—pharynx cancer	0.00216	0.00367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by FGFR in disease—EGFR—pharynx cancer	0.00216	0.00367	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR—EGFR—pharynx cancer	0.00214	0.00364	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by EGFR in Cancer—EGFR—pharynx cancer	0.00212	0.0036	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Metabolism—B4GALT5—pharynx cancer	0.00212	0.0036	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by PDGF—EGFR—pharynx cancer	0.00211	0.00359	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—EGFR—pharynx cancer	0.00203	0.00345	CbGpPWpGaD
Ingenol Mebutate—PRKCA—NGF signalling via TRKA from the plasma membrane—EGFR—pharynx cancer	0.00191	0.00325	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—pharynx cancer	0.00185	0.00314	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Integrated Pancreatic Cancer Pathway—TP53—pharynx cancer	0.00171	0.0029	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CD79A—pharynx cancer	0.0015	0.00255	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by NGF—EGFR—pharynx cancer	0.00147	0.0025	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Innate Immune System—EGFR—pharynx cancer	0.00146	0.00248	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—CDH1—pharynx cancer	0.00145	0.00247	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Hemostasis—TP53—pharynx cancer	0.00136	0.00231	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle, Mitotic—CCND1—pharynx cancer	0.00125	0.00213	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—CCND1—pharynx cancer	0.00112	0.0019	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling by GPCR—EGFR—pharynx cancer	0.000931	0.00158	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Immune System—EGFR—pharynx cancer	0.00085	0.00145	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Innate Immune System—EGFR—pharynx cancer	0.000839	0.00143	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—CDH1—pharynx cancer	0.000835	0.00142	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Disease—EGFR—pharynx cancer	0.000785	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Hemostasis—TP53—pharynx cancer	0.000782	0.00133	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Cell Cycle—TP53—pharynx cancer	0.000738	0.00125	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—CCND1—pharynx cancer	0.000701	0.00119	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—EGFR—pharynx cancer	0.00055	0.000935	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling by GPCR—EGFR—pharynx cancer	0.000535	0.000909	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Immune System—EGFR—pharynx cancer	0.000488	0.00083	CbGpPWpGaD
Ingenol Mebutate—PRKCD—Signaling Pathways—TP53—pharynx cancer	0.000462	0.000785	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Disease—EGFR—pharynx cancer	0.000451	0.000767	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—CCND1—pharynx cancer	0.000403	0.000684	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—EGFR—pharynx cancer	0.000316	0.000537	CbGpPWpGaD
Ingenol Mebutate—PRKCA—Signaling Pathways—TP53—pharynx cancer	0.000265	0.000451	CbGpPWpGaD
